Kungsleden Aktiebolag (OM:KLED) agreed to acquire Julius 1 in Malmö from Conpharm AB (publ) (OM:CONP B) for SEK 65 million on September 22, 2014. The transaction is expected to complete on October 1, 2014.

Kungsleden Aktiebolag (OM:KLED) completed the acquisition of Julius 1 in Malmö from Conpharm AB (publ) (OM:CONP B) in 2014.